正文：
近年来，海南自由贸易港的建设不断推进，一系列政策措施为企业降本增效提供了有力支持。近日，齐鲁制药(海南)有限公司完成了一种药品的申报备案，这标志着该公司有望成为享受“加工增值超30%免关税”政策的企业之一。
据公司董事长刘文民介绍，如果审核顺利，这将使该公司成为第三家享受到这项政策的企业。这项政策旨在通过降低关税成本，激发企业的创新活力和市场竞争力。
《海南自由贸易港建设总体方案》明确规定，对在海南自由贸易港与内地之间设立“二线”的货物，如果其加工增值超过30%，即可免征进口关税。这一政策自实施以来，已在海南自贸港落地生根，为众多企业带来了实实在在的利益。
齐鲁制药(海南)有限公司作为海南医药行业的试点企业，其生产的药品关键料件需要从海外进口，关税较高。因此，这项政策对于该公司来说，是一次重要的成本节约。在政策的支持下，该公司不仅有效降低了成本，还提高了产品的市场竞争力。
海南省政府通过一系列措施，如简化报关流程、减少表格填写等，解决了企业在申报过程中的堵点、痛点问题，使得政策实施更加顺畅。据统计，截至今年6月底，海南已有27家企业开展加工增值业务，内销货值52.5亿元，减免关税4.3亿元。
此外，海南省政府还进一步简化了政策审批流程，将审批权限下放至海南，使得企业申报更加简单快捷。这一系列深化改革措施，为海南自贸港的企业带来了新的发展机遇。
随着“加快建设海南自由贸易港”写入党的二十届三中全会《决定》，海南自贸港的改革步伐将进一步加快，政策也将迎来进一步的深化拓展。海南省政府表示，将继续深化加工增值内销免关税政策应用，吸引更多企业参与，推动海南自贸港建设迈上新台阶。
英语如下：
News Title: “Hainan Free Trade Port: Policies Help Enterprises Reduce Costs and Enhance Efficiency”
Keywords: Free Trade Port, Cost Reduction and Efficiency Enhancement, Policy Support
News Content:
Recently, the construction of Hainan Free Trade Port has been continuously advancing, with a series of policy measures providing strong support for enterprises to reduce costs and enhance efficiency. Recently, Qilu Pharmaceutical (Hainan) Co., Ltd. completed the filing and registration of a drug, marking the company as one of the enterprises that may benefit from the policy of “exemption from tariffs for goods with a processing gain exceeding 30%.”
According to Chairman Liu Wenmin of the company, if the review goes smoothly, it will make the company the third to enjoy this policy. This policy aims to stimulate the innovative vitality and market competitiveness of enterprises by reducing tariff costs.
The overall plan for the construction of the Hainan Free Trade Port clearly stipulates that for goods that are imported from the mainland to Hainan Free Trade Port and then exported, if the processing gain exceeds 30%, import tariffs can be exempted. Since its implementation, this policy has taken root in the Hainan Free Trade Port, bringing tangible benefits to many enterprises.
Qilu Pharmaceutical (Hainan) Co., Ltd., as a pilot enterprise in Hainan’s pharmaceutical industry, imports key raw materials from overseas for its production of drugs, which are subject to high tariffs. Therefore, this policy represents a significant cost savings for the company. With the support of the policy, the company has not only effectively reduced costs but also enhanced its market competitiveness.
The Hainan provincial government has addressed the bottlenecks and pain points in the declaration process for enterprises through a series of measures, such as simplifying customs clearance procedures and reducing the number of forms to fill out, making the implementation of the policy smoother. According to statistics, by the end of June this year, 27 enterprises in Hainan have been engaged in processing gain business, with a domestic sales value of 5.25 billion yuan and a tariff reduction of 430 million yuan.
In addition, the Hainan provincial government has further simplified the policy approval process by transferring the approval authority to Hainan, making it simpler and faster for enterprises to apply. These deepening reform measures have brought new development opportunities to enterprises in the Hainan Free Trade Port.
With the phrase “Accelerate the Construction of Hainan Free Trade Port” written into the Decision of the Third Plenary Session of the 20th Central Committee of the Communist Party of China, the pace of reform in the Hainan Free Trade Port will be further accelerated, and the policies will see further deepening and expansion. The Hainan provincial government has expressed its intention to continue deepening the application of the policy of exempting domestic sales from tariffs for processing gain, attracting more enterprises to participate, and pushing the construction of the Hainan Free Trade Port to a new level.
【来源】http://www.chinanews.com/gn/2024/08-13/10268022.shtml
Views: 1